These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2143993)

  • 1. In vivo concentrations of kinins and angiotensins.
    Shimamoto K; Nakagawa M; Iimura O
    Horm Metab Res Suppl; 1990; 22():75-9. PubMed ID: 2143993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
    Iimura O; Shimamoto K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
    Pellacani A; Brunner HR; Nussberger J
    Clin Sci (Lond); 1994 Nov; 87(5):567-74. PubMed ID: 7874846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
    Bönner G
    Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelation between the renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension.
    Ishida H; Shimamoto K; Nishitani T; Hosoda S; Yokoyama T; Nakahashi Y; Ando T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():329-36. PubMed ID: 3028077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K; Matsuki T; Iimura O
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific direct radioimmunoassay of angiotensin II (AT II) in human plasma and the effect of angiotensin converting enzyme (ACE) inhibitor.
    Abe F; Omata K; Yamada M; Tsunoda K; Sato T; Shimizu T; Ito S; Abe K; Nakazima M; Morimoto T; Takanashi N
    Immunopharmacology; 1999 Oct; 44(1-2):199-204. PubMed ID: 10604545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
    Tanaka S; Shimamoto K; Ando T; Nakahashi Y; Ura N; Hosoda S; Ishida H; Yamaji I; Yokoyama T; Masuda A
    Clin Exp Hypertens A; 1987; 9(2-3):605-9. PubMed ID: 3038424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramipril: a review of the new ACE inhibitor.
    Mills TP
    J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: evidence for a kinin-dependent mechanism.
    Scherf H; Pietsch R; Landsberg G; Kramer HJ; Düsing R
    Klin Wochenschr; 1986 Aug; 64(16):742-5. PubMed ID: 3020312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does kinin mediate the hypotensive action of angiotensin converting enzyme (ACE) inhibitors?
    Sharma JN
    Gen Pharmacol; 1990; 21(4):451-7. PubMed ID: 2199299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ramipril on arterial hemodynamics.
    Benetos A; Vasmant D; Thiéry P; Safar M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S153-6. PubMed ID: 1725030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases.
    Shimamoto K; Ishida H; Nakahashi Y; Nishitani T; Hosoda S; Yokoyama T; Tanaka S; Iimura O
    Jpn Circ J; 1984 Nov; 48(11):1228-35. PubMed ID: 6389920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.